Efimosfermin alfa
N/A
Report date: 2026/04/17 20:02:02
Base Information
Drug NameEfimosfermin alfa
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesGlaxosmithkline PlcBoston Pharmaceuticals Inc
Inactive CompaniesNovartis Pharma Ag
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A